Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CHE NYSE:DGX NYSE:DVA NYSE:LH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$418.08+1.4%$508.86$408.42▼$623.60$6.03B0.5161,266 shs278,714 shsDGXQuest Diagnostics$170.81+2.0%$174.01$144.87▼$182.38$18.72B0.461.36 million shs1.42 million shsDVADaVita$138.44-1.4%$140.44$131.76▼$179.60$10.60B1.09672,836 shs686,266 shsLHLabcorp$261.34+0.5%$256.06$209.38▼$283.47$21.77B0.78851,657 shs652,995 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed+1.24%-10.87%-11.34%-27.40%-26.67%DGXQuest Diagnostics+2.10%+1.44%-3.26%-4.02%+20.09%DVADaVita-1.31%-4.55%-2.98%-1.75%+1.33%LHLabcorp+0.69%-1.18%+0.50%+5.43%+21.31%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHEChemed4.972 of 5 stars3.45.03.34.92.32.52.5DGXQuest Diagnostics4.9425 of 5 stars2.35.04.24.73.42.52.5DVADaVita4.4526 of 5 stars2.02.00.04.52.92.53.8LHLabcorp4.8252 of 5 stars3.34.02.54.23.92.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEChemed 2.75Moderate Buy$579.7538.67% UpsideDGXQuest Diagnostics 2.67Moderate Buy$186.008.89% UpsideDVADaVita 2.00Hold$167.4020.92% UpsideLHLabcorp 2.62Moderate Buy$289.5810.81% UpsideCurrent Analyst Ratings BreakdownLatest CHE, LH, DGX, and DVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/31/2025CHEChemedRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$640.00 ➝ $589.007/31/2025CHEChemedOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$650.00 ➝ $580.007/25/2025CHEChemedJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageHold$500.007/25/2025LHLabcorpUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$282.00 ➝ $305.007/25/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$290.00 ➝ $310.007/25/2025LHLabcorpEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$285.00 ➝ $300.007/25/2025LHLabcorpMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$283.00 ➝ $306.007/25/2025LHLabcorpRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$290.00 ➝ $302.007/23/2025DGXQuest DiagnosticsEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$185.007/23/2025DGXQuest DiagnosticsWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform7/23/2025DGXQuest DiagnosticsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$190.00 ➝ $192.00(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEChemed$2.51B2.43$26.08 per share16.03$81.92 per share5.10DGXQuest Diagnostics$9.87B1.93$13.78 per share12.40$64.97 per share2.63DVADaVita$12.82B0.82$18.86 per share7.34$4.83 per share28.66LHLabcorp$13.01B1.68$22.51 per share11.61$101.23 per share2.58Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEChemed$302M$19.4521.5017.942.2111.56%25.83%17.77%N/ADGXQuest Diagnostics$871M$8.3520.4616.282.229.01%15.24%6.64%N/ADVADaVita$936.34M$10.0913.7210.890.976.63%176.11%4.66%8/5/2025 (Estimated)LHLabcorp$746M$9.0628.8514.901.665.66%15.45%7.02%N/ALatest CHE, LH, DGX, and DVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025DVADaVita$2.70N/AN/AN/A$3.36 billionN/A7/29/2025Q2 2025CHEChemed$6.02$4.27-$1.75$3.57$650.60 million$618.80 million7/24/2025Q2 2025LHLabcorp$4.14$4.35+$0.21$2.84$3.49 billion$3.53 billion7/22/2025Q2 2025DGXQuest Diagnostics$2.57$2.62+$0.05$2.47$2.73 billion$2.76 billion5/12/2025Q1 2025DVADaVita$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHEChemed$2.000.48%N/A10.28%16 YearsDGXQuest Diagnostics$3.201.87%N/A38.32%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLabcorp$2.881.10%N/A31.79%N/ALatest CHE, LH, DGX, and DVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/10/2025LHLabcorpquarterly$0.721.11%8/28/20259/11/20255/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/20255/20/2025CHEChemedquarterly$0.500.3%5/29/20255/29/20256/17/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEChemedN/A1.861.70DGXQuest Diagnostics0.711.090.99DVADaVita23.181.251.20LHLabcorp0.611.501.32Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEChemed95.85%DGXQuest Diagnostics88.06%DVADaVita90.12%LHLabcorp95.94%Insider OwnershipCompanyInsider OwnershipCHEChemed3.29%DGXQuest Diagnostics8.16%DVADaVita2.00%LHLabcorp0.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHEChemed15,69514.63 million14.15 millionOptionableDGXQuest Diagnostics56,000111.82 million102.70 millionOptionableDVADaVita76,00075.50 million73.99 millionOptionableLHLabcorp70,00083.70 million83.00 millionOptionableCHE, LH, DGX, and DVA HeadlinesRecent News About These CompaniesLabcorp Holdings Inc. (NYSE:LH) Director Sells $529,900.00 in Stock2 hours ago | marketbeat.comDwight Gary Gilliland Sells 2,000 Shares of Labcorp Holdings Inc. (NYSE:LH) StockAugust 2 at 6:57 AM | insidertrades.comMackenzie Financial Corp Grows Stake in Labcorp Holdings Inc. (NYSE:LH)August 2 at 5:12 AM | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Purchases 1,222 Shares of Labcorp Holdings Inc. (NYSE:LH)August 2 at 5:01 AM | marketbeat.comTD Asset Management Inc Purchases 10,411 Shares of Labcorp Holdings Inc. (NYSE:LH)August 2 at 5:01 AM | marketbeat.comLabcorp Holdings Inc. (NYSE:LH) Shares Purchased by Natixis Advisors LLCAugust 1 at 6:04 AM | marketbeat.comTredje AP fonden Increases Holdings in Labcorp Holdings Inc. (NYSE:LH)August 1 at 5:54 AM | marketbeat.com1 Healthcare Stock to Consider Right Now and 2 That UnderwhelmJuly 31 at 5:14 PM | uk.finance.yahoo.comThe 5 Most Interesting Analyst Questions From Labcorp’s Q2 Earnings CallJuly 31 at 5:14 PM | msn.comLabcorp Holdings (LH) Unveils Test Finder: AI Tool for Streamlined Lab Test SelectionJuly 31 at 5:14 PM | finance.yahoo.comWhy Labcorp Holdings (LH) is a Top Momentum Stock for the Long-TermJuly 31 at 10:51 AM | zacks.comPacer Advisors Inc. Decreases Position in Labcorp Holdings Inc. (NYSE:LH)July 31 at 4:49 AM | marketbeat.comLabcorp Holdings (LH) Launches CE-Marked Test for Cancer Care Expansion in EUJuly 30 at 12:47 AM | finance.yahoo.comLabcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test SearchJuly 30 at 7:12 AM | prnewswire.comInsider Selling: Labcorp Holdings Inc. (NYSE:LH) Director Sells 3,500 Shares of StockJuly 29, 2025 | marketbeat.comWhy Labcorp Holdings (LH) is a Top Value Stock for the Long-TermJuly 29, 2025 | zacks.comFirst Foundation Advisors Has $5.31 Million Stake in Labcorp Holdings Inc. (NYSE:LH)July 29, 2025 | marketbeat.comLabcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EUJuly 29, 2025 | prnewswire.comLabcorp Holdings Inc. (NYSE:LH) Director Kerrii B. Anderson Sells 3,500 SharesJuly 29, 2025 | insidertrades.comFY2026 EPS Estimates for Labcorp Increased by AnalystJuly 29, 2025 | americanbankingnews.comGalvin Gaustad & Stein LLC Cuts Position in Labcorp Holdings Inc. (NYSE:LH)July 28, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendJoby vs. Archer: Which eVTOL Stock Is Better for Your Portfolio?By Jeffrey Neal Johnson | July 14, 2025View Joby vs. Archer: Which eVTOL Stock Is Better for Your Portfolio?The Meteoric Rise of Rocket Lab: A Space Stock to WatchBy Ryan Hasson | July 11, 2025View The Meteoric Rise of Rocket Lab: A Space Stock to Watch3 High-Risk, High-Reward Stocks With Explosive UpsideBy Nathan Reiff | July 16, 2025View 3 High-Risk, High-Reward Stocks With Explosive UpsideQualcomm: Undervalued Chip Stock in Breakout UptrendBy Sam Quirke | July 17, 2025View Qualcomm: Undervalued Chip Stock in Breakout UptrendCHE, LH, DGX, and DVA Company DescriptionsChemed NYSE:CHE$418.08 +5.78 (+1.40%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$438.00 +19.93 (+4.77%) As of 08/1/2025 04:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Quest Diagnostics NYSE:DGX$170.81 +3.40 (+2.03%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$170.86 +0.04 (+0.03%) As of 08/1/2025 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$138.44 -1.93 (-1.37%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$138.43 -0.01 (-0.01%) As of 08/1/2025 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Labcorp NYSE:LH$261.34 +1.26 (+0.48%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$261.42 +0.09 (+0.03%) As of 08/1/2025 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
